A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Contemporary estrogen-progestin contraceptives are associated with an increased risk for ischemic stroke and myocardia ...

Certain contraceptives may carry a slightly increased risk of heart attacks and strokes in women, according to a large new study.While the overall risk is very low, researchers said medics should be ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study was aimed at exploring immune-related genes and their expression changes in myocardial ...

A real-world Danish registry study showed a significant increased relative risk, but small absolute risk, for stroke and ...

A new study published in JSCAI has revealed a lower risk of cardiovascular events for patients with Type 1 diabetes (often ...

The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term ...

A 17-year analysis found sex-based differences in the prevalence and treatment of patients with ST-segment elevation MI with nonobstructive coronary arteries, but the mortality risk remains similar.

Data suggest a dose-related association between progestin-only products and arterial thrombotic risk. Various hormonal contraceptives were linked to incident cardiovascular disease in an analysis of ...

Premier's 50 Top Cardiovascular Hospitals uses public data to spotlight the best cardiovascular hospitals across the nation.